Chronic fatigue syndrome (CFS)/Myalgic Encephalomyelitis (ME) and fibromyalgia (FM) are both debilitating syndromes with complex polysymptomatology. Early research infers that a relationship may exist even though the diagnosis provided may influence the management trajectory. In the absence of a diagnostic test and treatment, this study aims to confirm the symptoms and their severity, which may infer a relationship and influence future research.
Method:
A quasi-experimental design was utilised, using Internet-based self-assessment questionnaires focusing on nine symptom areas: criteria, pain, sleep, fatigue, anxiety and depression, health-related quality of life, self-esteem and locus of control. The questionnaires used for data collection are as follows: the American Centre for Disease Control and Prevention Symptom Inventory for CFS/ME (American CDC Symptom Inventory); the American College of Rheumatology (ACR) Criteria for FM; Fibromyalgia Impact Questionnaire (FIQ); McGill Pain Questionnaire (MPQ); Multidimensional Fatigue Inventory (MFI); Pittsburgh Sleep Quality Index (PSQI); Health-Related Quality of Life SF-36 V2 (HRQoL SF-36 V2); Hospital Anxiety and Depression Scale (HADS); Multidimensional Health Locus of Control (MHLOC) and the Rosenberg Self-Esteem Scale (RSES).
Setting and participants:
Participants were recruited from two distinct community groups, namely CFS/ME (n = 101) and FM (n = 107). Participants were male and female aged 17 (CFS/ME mean age 45.5 years; FM mean age 47.2 years).
Results:
All participants in the CFS/ME and FM groups satisfied the requirements of their individual criteria. Results confirmed that both groups experienced the debilitating symptoms measured, with the exception of anxiety and depression, impacting on their quality of life. Results suggest a relationship between CFS/ME and FM, indicating the requirement for future research.
RomanoGFTomassiSRussellA, et al. Fibromyalgia and chronic fatigue syndrome: the underlying biology and related theoretical issues. Adv Psychosom Med2015; 34: 61–77.
2.
WolfeFClauwDJFitzcharlesMA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken)2010; 62(5): 600–610.
3.
Action for ME. Ignorance, injustice and neglect: an investigation into NHS specialist services provision for people with ME/CFS, 2012
4.
JohnstonSBrenuEWStainesDR, et al. The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. Ann Epidemiol2013; 23(6): 371–376.
5.
Martinez-LavinMInfanteOLermaC. Hypothesis: the chaos and complexity theory may help our understanding of fibromyalgia and similar maladies. Semin Arthritis Rheum2008; 37(4): 260–264.
6.
FukudaKStrausSEHickieI, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med1994; 121(12): 953–959.
7.
WolfeFSmytheHAYunusMB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheumatol1990; 33: 160–172.
8.
National Institute for Health and Clinical Excellence 53. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of CFS/ME in adults and children. London: NICE, 2007.
9.
GoldenburgDLSimmsRWGeigenA, et al. High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis Rheumatol1990; 33: 381–387.
10.
NorregaardJBulowPMPrescottE, et al. A four-year follow-up study in fibromyalgia relationship to chronic fatigue syndrome. Scand J Rheumatol1993; 22(1): 35–38.
11.
SullivanPFSmithWBuchwaldD. Latent class analysis of symptoms associated with chronic fatigue syndrome and fibromyalgia. Psychol Med2002; 32(5): 881–888.
12.
MehendaleAGoldmanMP. Fibromyalgia syndrome, idiopathic widespread persistent pain or syndrome of myalgic encephalomyelopathy (SME): what is its nature?Pain Pract2002; 2(1): 35–46.
13.
GeisserMEGracelyRHGieseckeT, et al. The association between experimental and clinical pain measures among persons with fibromyalgia and chronic fatigue syndrome. Eur J Pain2007; 11(2): 202–207.
14.
KopWJLydenABerlinAA, et al. Ambulatory monitoring of physical activity and symptoms in fibromyalgia and chronic fatigue syndrome. Arthritis Rheum2005; 52: 269–303.
15.
WeirPTHarlanGANkoyFL, et al. The incidence of fibromyalgia and its associated comorbidities: a population based retrospective cohort study based on International Classification of Diseases, 9th revision codes. J Clin Rheumatol2006; 12: 124–128.
16.
WesselySChalderTHirschS, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health1997; 87: 1449–1455.
17.
WagnerDNisenbaumRHeimC, et al. Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr2005; 3: 8, https://www.ncbi.nlm.nih.gov/pubmed/16042777 (accessed 12 October 2008).
18.
VermeulenRCW. Translation and validation of the Dutch language version of the CDC Symptom Inventory for assessment of chronic fatigue syndrome (CFS). Popul Health Metr2006; 4: 12.
19.
HawkCJasonLATorres-HardingS. Reliability of a chronic fatigue syndrome questionnaire. J. Chronic Fatigue Syndr2006; 13: 41–66.
20.
BennettR. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development current version operating characteristics and uses clinical and experimental. Rheumatol2005; 23: 154–162.
21.
BurckhardtCSClarkSRBennettRM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol1991; 18: 728–733.
22.
MeenanRFGertmanPMMasonJ. Measuring health status in arthritis. The Arthritis Impact Measurement Scales. Arthritis Rheum1980; 23(2): 146–152.
23.
MelzackR. The McGill Pain Questionnaire: major properties and scoring methods. Pain1975; 1(3): 277–299.
24.
NgamkhamSVincentCFinneganL, et al. The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review. Pain Manag Nurs2012; 13(1): 27–51.
25.
SmetsEMGarssenBBonkeB, et al. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res1995; 39(3): 315–325.
26.
LinJSBrimmerDMaloneyEM, et al. Further validation of the Multidimensional Fatigue Inventory in a US adult population. Popul Health Metr2009; 7: 18, www.pophealthmetrics.com/content/7/1/18
27.
BuysseDJReynoldsCFIIIMonkTH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res1989; 28(2): 193–213.
28.
SmithMWegnerT. Measures of sleep. The Insomnia Severity Index, Medical Outcomes Study (MOS) Sleep Scale, Pittsburgh Sleep Diary (PSD) and Pittsburgh Sleep Quality Index (PSQI). Arthritis and Rheum2003; 49: 184–196.
29.
VeigaDMCunaliRBonottoD, et al. Sleep quality in patients with temporomandibular disorder: a systematic review. Sleep Sci2013; 6: 120–124.
30.
BurckhardtCSClarkSRBennettRM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol1993; 20(3): 475–479.
31.
WareJEJrKosinskiMGandekB, et al. The factor structure of the SF-36 health survey in 10 countries: results from the IQOLA project. J Clin Epidemiol1998; 51(11): 1159–1165.
32.
PerrotSVicautEServantD, et al. Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: the DEFI Study (determination of epidemiology of fibromyalgia). BMC Musculoskelet Disord2011; 12: 224, https://www.ncbi.nlm.nih.gov/pubmed/21981821
33.
WareJEJrSherbourneCD. The MOS 36-item Short-Form Health Survey (SF-36): I conceptual framework and item selection. Med Care1992; 30(6): 473–483.
34.
ZigmondASSnaithRP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand1983; 67: 361–370.
35.
BjellandIDahlAAHaugTT, et al. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res2002; 52(2): 69–77.
36.
McCuePMartinCRBuchananT, et al. An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in individuals with chronic fatigue syndrome. Psychol Health Med2003; 8(4): 425–439.
37.
WallstonKASteinMJSmithCA. Form C of the MHLC scales a condition-specific measure of locus of control. J Pers Assess1994; 63(3): 534–553.
38.
MichielsenHJVan HoudenhoveBLeirsI, et al. Depression, attribution style and self-esteem in chronic fatigue syndrome and fibromyalgia patients: is there a link?Clin Rheumatol2006; 25(2): 183–188.
39.
WhiteCSchweitzerR. The role of personality in the development and perpetuation of chronic fatigue syndrome. J Psychosom Res2010; 48: 515–524.
40.
SinclairSJBlaisMAGanslerDA, et al. Psychometric properties of the Rosenberg Self-Esteem Scale: overall and across demographic groups living within the United States. Eval Health Prof2010; 33(1): 56–80.
41.
MartinCRThompsonDRChanDS. An examination of the psychometric properties of the Rosenberg Self Esteem Scale (RSES) in Chinese acute Coronary Syndrome (ACS). Psychol Health Med2006; 11(4): 507–521.
42.
RosenbergM. Society and the adolescent self-image. Princeton, NJ: Princeton University Press, 1965.
43.
BennettRMBushmakinAGCappelleriJC, et al. Minimal important difference in the Fibromyalgia Impact Questionnaire. J Rheumatol2009; 36: 1304–1311.
44.
WallstonKAWallstonBSDeVellisR. Development of the Multidimensional Health Locus of Control (MHLC) scales. Health Educ Monogr1978; 6(2): 160–170.
45.
WilkieDJHuangHYReillyN, et al. Norrciceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage2001; 22: 899–910.
46.
MarshallRPaulLMcFadyenAK, et al. Pain characteristics of people with chronic fatigue syndrome. J Musculoskelet Pain2010; 18: 127–137.
47.
StewartALHaysRDWareJEJr.The MOS short Form General Health Survey: reliability and validity in a patient population. Med Care1988; 26(7): 724–735.
FriedbergFJasonLA. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment. J Clin Psychol2001; 57(4): 433–455.
50.
VincentALahrmBDWolfeF, et al. Prevalence of fibromyalgia: a population-based study in Olmstead County, Minnesota, utilising the Rochester Epidemiology Project. Arthritis Care Res2013; 65: 286–792.
51.
Craggs-HintonC. Living with fibromyalgia (Overcoming Common Problems). New ed. London: Sheldon Press, 2010.
52.
HauserWWolfeF. Diagnosis and diagnostic tests for fibromyalgia (syndrome). Reumatismo2012; 64(4): 194–205.
53.
MeasePJPalmerRHWangY. Effects of Malcipran on the multidimensional aspects of fatigue to pain and function pooled analysis of 3 fibromyalgia trials. J Clin Rheumatol2014; 20: 195–202.
54.
WilkieDJSavedraMCHolzemerWL, et al. Use of the McGill Pain Questionnaire to measure pain: a meta-analysis. Nurs Res1990; 39(1): 36–41.
55.
PirinsJBVan der MeerJWBleijenbergG. Chronic fatigue syndrome. Lancet2006; 367: 346–355.
56.
LowryTJPakenhamKI. Health related quality of life in chronic fatigue syndrome: predictors of physical functioning and psychological distress. Psychol Health Med2008; 13(2): 222–238.
57.
NunezMFernandez-SolaJNunezE, et al. Health related quality of life in patients with chronic fatigue syndrome: group cognitive behavioral therapy and graded exercise versus usual treatment. A randomised controlled trial with 1 year follow up. Clin Rheumatol2011; 30: 381–389.
